Abiopharma

New Form 10-Q - GILEAD SCIENCES, INC. Filed: 2025-08-07 AccNo: 0000882095-25-000032 Size: 11 MB

New Form 4 - Journey Medical Corp Filed: 2025-08-07 AccNo: 0001104659-25-075260 Size: 5 KB

New Form 10-Q - Ascend Wellness Holdings, Inc. Filed: 2025-08-07 AccNo: 0001628280-25-038988 Size: 11 MB

New Form 3 - Nexalin Technology, Inc. Filed: 2025-08-07 AccNo: 0001829126-25-005929 Size: 5 KB

New Form S-3 - Ginkgo Bioworks Holdings, Inc. Filed: 2025-08-07 AccNo: 0001628280-25-038985 Size: 451 KB

New Form SCHEDULE 13D/A - Vigil Neuroscience, Inc. Filed: 2025-08-07 AccNo: 0001415889-25-021288 Size: 39 KB

New Form 8-K - Sana Biotechnology, Inc. Filed: 2025-08-07 AccNo: 0001193125-25-175571 Size: 547 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 10-Q - NATIONAL HEALTHCARE CORP Filed: 2025-08-07 AccNo: 0001437749-25-025500 Size: 8 MB

New Form 8-K - Tectonic Therapeutic, Inc. Filed: 2025-08-07 AccNo: 0001193125-25-175567 Size: 8 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form CERT - BIOVIE INC. Filed: 2025-08-07 AccNo: 0001354457-25-000789 Size: 126 KB

New Form 10-Q - GLOBUS MEDICAL INC Filed: 2025-08-07 AccNo: 0001562762-25-000200 Size: 20 MB

New Form 10-Q - Ginkgo Bioworks Holdings, Inc. Filed: 2025-08-07 AccNo: 0001628280-25-038982 Size: 8 MB

New Form 8-K - Ginkgo Bioworks Holdings, Inc. Filed: 2025-08-07 AccNo: 0001628280-25-038981 Size: 448 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics

Ginkgo Bioworks - Ginkgo Bioworks Reports Second Quarter 2025 Financial Results